Description

Anastrozole (Arimidex)

Selective Aromatase Inhibitor | Estrogen-Synthesis Research & Pharmaceutical Compound

Anastrozole, marketed under the brand name Arimidex, is a potent, selective, non-steroidal aromatase inhibitor. It works by inhibiting the aromatase enzyme involved in the conversion of androgens to estrogens, thereby substantially reducing estrogen production.

Arimidex is an established prescription medicine and is FDA-approved for specific breast-cancer indications in postmenopausal women. It should therefore be distinguished from experimental research chemicals and dietary supplements.

Key Characteristics

  • Generic Name: Anastrozole
  • Brand Name: Arimidex
  • Drug Class: Aromatase inhibitor
  • Compound Type: Non-steroidal aromatase inhibitor
  • Common Tablet Strength: 1mg
  • Primary Pharmacological Target: Aromatase enzyme
  • Research Areas: Estrogen biosynthesis, endocrine signaling, steroid metabolism, and pharmacology

Mechanism of Action

Anastrozole selectively inhibits aromatase, an enzyme responsible for the conversion of androgens such as androstenedione and testosterone into estrogenic compounds.

By suppressing aromatase activity, anastrozole lowers circulating estradiol and other estrogen concentrations. This mechanism is particularly relevant to endocrine research involving estrogen-dependent biological pathways.

Research Applications

Anastrozole may be investigated in controlled research involving:

  • Aromatase enzyme inhibition
  • Estrogen biosynthesis
  • Endocrine signaling
  • Steroid metabolism
  • Estrogen-receptor-related research
  • Pharmacokinetic and pharmacodynamic studies
  • Drug interaction research
  • Analytical identification and characterization

Research Advantages

Selective Aromatase Inhibition

Provides a well-characterized model compound for studying suppression of aromatase-mediated estrogen production.

Endocrine Research Utility

Useful for investigating relationships between androgen metabolism, estrogen synthesis, and downstream endocrine signaling.

Established Pharmacology

Anastrozole has a substantial clinical and pharmacological research history, making it useful as a reference compound in laboratory studies.

Analytical Compatibility

Suitable for analytical workflows evaluating compound identity, purity, concentration, stability, and formulation characteristics.

Pharmaceutical Information

FDA-approved Arimidex tablets contain 1mg of anastrozole and are used for specific breast-cancer indications, including adjuvant treatment of postmenopausal women with hormone-receptor-positive early breast cancer and certain advanced or metastatic breast-cancer settings.

Safety Considerations

Anastrozole is a pharmacologically active medicine and can produce clinically significant adverse effects. The FDA prescribing information warns of possible decreases in bone mineral density, increases in cholesterol, and cardiovascular risks in certain patients, among other adverse reactions.

Because of its potent endocrine activity, it should not be presented as a general wellness product or dietary supplement.

Quality & Documentation

For analytical or laboratory applications, relevant documentation may include:

  • Compound identity
  • Purity
  • Assay/content
  • Batch or lot number
  • Certificate of Analysis (COA)
  • Stability information
  • Applicable analytical test results

Important Disclaimer

Anastrozole (Arimidex) is a prescription pharmaceutical compound, not a dietary supplement. This content is provided for scientific, product-identification, and legitimate research/analytical purposes only.

Human use should follow an authorized product’s prescribing information and qualified medical supervision. This description does not provide dosing instructions or recommend non-prescribed use.